Literature DB >> 7689467

Stimulatory (EP1 and EP3) and inhibitory (EP2) prostaglandin E2 receptors in isolated ileal smooth muscle cells.

A Botella1, M Delvaux, J Fioramonti, J Frexinos, L Bueno.   

Abstract

Isolated smooth muscle cells from the circular layer of pig and guinea-pig ileum were used to study the effect of prostaglandin E2 (PGE2) and three PGE2 receptor (EP) agonists; iloprost (EP1), butaprost (EP2) and enprostil (EP3). In pig cells, PGE2 and enprostil induced cell contraction (22.1 and 21.5% shortening of cell length, obtained at 10 nM for PGE2 and 1 nM for enprostil, respectively). Iloprost and butaprost had no contractile effect. However, the cholecystokinin octapeptide (CCK-8; 10 nM)-induced contraction was inhibited when cells were preincubated with iloprost or butaprost. In guinea-pig cells, PGE2, butaprost and iloprost induced cell contraction, whereas enprostil had no effect (23.1% for 10 nM PGE2, 22.8% for 1 nM butaprost and 22.6% for 10 nM iloprost). Preincubation with SC19220 (EP1 antagonist) inhibited the PGE2-, butaprost- and iloprost-induced contractions. When the contractile effect of PGE2, butaprost and iloprost was inhibited by addition of SC19220, these agents inhibited the cell contraction induced by CCK-8 (1 nM). Smooth muscle cells from guinea-pig and pig ileum express two PGE2 receptor subtypes that induce opposite effect. EP1 and EP3 receptors mediate cell contraction in guinea-pig and pig, respectively, whereas EP2 receptors mediate cell relaxation in both species.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689467     DOI: 10.1016/0014-2999(93)90102-n

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  Membrane TLR signaling mechanisms in the gastrointestinal tract during sepsis.

Authors:  B M Buchholz; A J Bauer
Journal:  Neurogastroenterol Motil       Date:  2010-03       Impact factor: 3.598

2.  TRPV4 Channel Signaling in Macrophages Promotes Gastrointestinal Motility via Direct Effects on Smooth Muscle Cells.

Authors:  Jialie Luo; Aihua Qian; Landon K Oetjen; Weihua Yu; Pu Yang; Jing Feng; Zili Xie; Shenbin Liu; Shijin Yin; Dari Dryn; Jizhong Cheng; Terrence E Riehl; Alexander V Zholos; William F Stenson; Brian S Kim; Hongzhen Hu
Journal:  Immunity       Date:  2018-06-26       Impact factor: 31.745

Review 3.  Prostaglandin E2 receptor distribution and function in the gastrointestinal tract.

Authors:  I Dey; M Lejeune; K Chadee
Journal:  Br J Pharmacol       Date:  2006-10-02       Impact factor: 8.739

4.  Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease.

Authors:  P J Roberts; K Morgan; R Miller; J O Hunter; S J Middleton
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

5.  Prophylactic and therapeutic benefits of COX-2 inhibitor on motility dysfunction in bowel obstruction: roles of PGE₂ and EP receptors.

Authors:  You-Min Lin; Sushil K Sarna; Xuan-Zheng Shi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-28       Impact factor: 4.052

6.  Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.

Authors:  L Walch; V de Montpreville; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

7.  Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine.

Authors:  Anaid Shahbazian; Akos Heinemann; Bernhard A Peskar; Peter Holzer
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

8.  Prostanoid EP3 receptor agonist sulprostone enhances pacemaker activity of colonic interstitial cells of Cajal.

Authors:  Man Woo Kim; Han Yi Jiao; Seok Won Kim; Chan Guk Park; Mei Jin Wu; Chansik Hong; Seok Choi; Jae Yeoul Jun
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-06       Impact factor: 3.000

9.  Cloning and expression of the rabbit prostaglandin EP2 receptor.

Authors:  Youfei Guan; Brett A Stillman; Yahua Zhang; André Schneider; Osamu Saito; Linda S Davis; Reyadh Redha; Richard M Breyer; Matthew D Breyer
Journal:  BMC Pharmacol       Date:  2002-06-27

10.  Lubiprostone Increases Small Intestinal Smooth Muscle Contractions Through a Prostaglandin E Receptor 1 (EP1)-mediated Pathway.

Authors:  Walter W Chan; Hiroshi Mashimo
Journal:  J Neurogastroenterol Motil       Date:  2013-07-08       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.